Surgery Partners Inc
F:1SP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Surgery Partners Inc
F:1SP
|
US |
|
D
|
Duke Energy Corp
SWB:D2MN
|
US |
|
M
|
Murata Manufacturing Co Ltd
XMUN:MUR1
|
JP |
|
G
|
Grammer AG
XMUN:GMM
|
DE |
|
W
|
WP Carey Inc
F:WPY
|
US |
|
O
|
Otis Worldwide Corp
F:4PG
|
US |
|
G
|
General Mills Inc
XBER:GRM
|
US |
|
V
|
Vericel Corp
XMUN:ATQP
|
US |
|
T
|
Tonnellerie Francois Freres SA
PAR:TFF
|
FR |
Wall St Price Targets
1SP Price Targets Summary
Surgery Partners Inc
According to Wall Street analysts, the average 1-year price target for 1SP is 21.25 EUR with a low forecast of 16.05 EUR and a high forecast of 28.61 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1SP's stock price target?
Price Target
21.25
EUR
According to Wall Street analysts, the average 1-year price target for 1SP is 21.25 EUR with a low forecast of 16.05 EUR and a high forecast of 28.61 EUR.
What is the Revenue forecast for Surgery Partners Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Surgery Partners Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Surgery Partners Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 3 years is 0%.
What is the Pre-Tax Income forecast for Surgery Partners Inc?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 16%.
